https://orcid.org/0000-0001-8150-075X
References
- Tsuda K, Yamamoto K, Leppold C, Tanimoto T, Kusumi E, Komatsu T, Kami M. Trends of media coverage on human papillomavirus vaccination in Japanese newspapers. Clin Infect Dis. 2016;63(12):1634–38. doi:10.1093/cid/ciw647.
- Simms KT, Hanley SJB, Smith MA, Keane A, Canfell K. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020;5(4):e223–e234. doi:10.1016/S2468-2667(20)30010-4.
- Yagi A, Ueda Y, Nakagawa S, Ikeda S, Tanaka Y, Sekine M, Miyagi E, Enomoto T, Kimura T. Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine. Sci Rep. 2020;10(1):15945. doi:10.1038/s41598-020-73106-z.
- Tanaka Y. Time to resume active recommendation of the HPV vaccine in Japan. Lancet Oncol. 2020;21(12):1552–53. doi:10.1016/S1470-2045(20)30608-2.
- Ministry of Health, Labour and Welfare of Japan. HPV Vaccine adverse event reports in the National Committee on Vaccine Safety [accessed 2021 September 3]. https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html .
- Shiomi M, Ueda Y, Abe H, Yagi A, Sakiyama K, Kimura T, Tanaka Y, Ohmichi M, Ichimura T, Sumi T, et al. A survey of Japanese mothers on the effectiveness of the Ministry of Health, Labor and Welfare’s revised HPV vaccine leaflet. Hum Vaccin Immunother. 2020;16(10):2555–58. doi:10.1080/21645515.2020.1723362.
- Ugumori N, Ueda Y, Yagi A, Abe H, Shiomi M, Nakagawa S, Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, et al. A potential means to help the HPV vaccine penetrate the Japanese public while under the continued suspension of governmental recommendation. Hum Vaccin Immunother. 2021;17(9):3096–101. doi:10.1080/21645515.2021.1910001.
- Okuhara T, Ishikawa H, Okada M, Kato M, Kiuchi T. Persuasiveness of statistics and patients’ and mothers’ narratives in human papillomavirus vaccine recommendation messages: a randomized controlled study in Japan. Front Public Health. 2018;6:105. doi:10.3389/fpubh.2018.00105.
- Ishiwada N, Suzuki C, Hasebe S, Tsuchiya A, Takeuchi N, Hishiki H, Sato Y, Sugita K. The effects of health education on health science teachers’ intention to recommend adolescent HPV vaccine for female students in Japan. Hum Vaccin Immunother. 2020;16(11):2752–57. doi:10.1080/21645515.2020.1732163.
- Nagase Y, Ueda Y, Abe H, Yagi A, Sawada M, Nakagawa S, Hiramatsu K, Egawa-Takata T, Matsuzaki S, Kobayashi E, et al. Changing attitudes in Japan toward HPV vaccination: a 5-year follow-up survey of obstetricians and gynecologists regarding their current opinions about the HPV vaccine. Hum Vaccin Immunother. 2020;16(8):1808–13. doi:10.1080/21645515.2020.1712173.
- Arana JE, Harrington T, Cano M, Lewis P, Mba-Jonas A, Rongxia L, Stewart B, Markowitz LE, Shimabukuro TT. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. Vaccine. 2018;36(13):1781–88. doi:10.1016/j.vaccine.2018.02.034.